InvestorsHub Logo
Followers 25
Posts 2345
Boards Moderated 0
Alias Born 06/20/2020

Re: NM7 post# 199808

Monday, 01/10/2022 9:56:25 AM

Monday, January 10, 2022 9:56:25 AM

Post# of 232961
"CytoDyn expects to file the BLA for leronlimab for the treatment of HIV with FDA in the first quarter of 2022," stated Dr. Nader Pourhassan, President and CEO of CytoDyn.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News